SAM
PFE icon

Satovsky Asset Management’s Pfizer PFE Stock Holding History

Satovsky Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Sell
11,584
-1,272
-10% -$33.3K 0.04% 58
2026
Q1 		$361K Buy
12,856
+148
+1% +$3.94K 0.06% 44
2025
Q4 		$316K Buy
12,708
+208
+2% +$5.25K 0.06% 44
2025
Q3 		$318K Buy
12,500
+214
+2% +$5.28K 0.06% 45
2025
Q2 		$298K Sell
12,286
-445
-3% -$10.4K 0.06% 43
2025
Q1 		$323K Buy
12,731
+106
+0.8% +$2.77K 0.07% 36
2024
Q4 		$335K Sell
12,625
-814
-6% -$22.1K 0.08% 30
2024
Q3 		$389K Buy
13,439
+1,037
+8% +$30.3K 0.09% 29
2024
Q2 		$347K Buy
12,402
+285
+2% +$7.85K 0.08% 30
2024
Q1 		$336K Buy
12,117
+327
+3% +$9.07K 0.1% 28
2023
Q4 		$339K Buy
11,790
+158
+1% +$4.78K 0.11% 29
2023
Q3 		$386K Buy
11,632
+81
+0.7% +$2.86K 0.13% 26
2023
Q2 		$424K Buy
11,551
+677
+6% +$26.4K 0.14% 25
2023
Q1 		$444K Buy
10,874
+109
+1% +$4.71K 0.17% 22
2022
Q4 		$552K Buy
10,765
+88
+0.8% +$4.22K 0.23% 20
2022
Q3 		$467K Buy
10,677
+92
+0.9% +$4.47K 0.27% 18
2022
Q2 		$555K Sell
10,585
-22
-0.2% -$1.12K 0.32% 17
2022
Q1 		$549K Buy
10,607
+188
+2% +$9.76K 0.37% 16
2021
Q4 		$615K Buy
10,419
+75
+0.7% +$3.72K 0.41% 14
2021
Q3 		$445K Buy
10,344
+86
+0.8% +$3.81K 0.33% 13
2021
Q2 		$402K Buy
10,258
+103
+1% +$4K 0.31% 14
2021
Q1 		$368K Buy
10,155
+168
+2% +$5.96K 0.33% 14
2020
Q4 		$368K Buy
+9,987
New +$366K 0.35% 15

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Satovsky Asset Management's PFE Position: Q2 2026 in Review

Satovsky Asset Management reduced its Pfizer (PFE) stake by 9.9% in Q2 2026, selling an estimated $33.3K and leaving 11,584 shares worth $279K. The position accounts for 0.04% of the portfolio, ranked #58.

Satovsky Asset Management first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $615K in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Satovsky Asset Management held 11,584 shares of Pfizer worth $279K as of Q2 2026.
  • Satovsky Asset Management sold 1,272 Pfizer shares in Q2 2026, an estimated $33.3K.
  • Pfizer made up 0.04% of Satovsky Asset Management's portfolio in Q2 2026, its #58 holding.
  • Satovsky Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Satovsky Asset Management's Pfizer position peaked at $615K in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Satovsky Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.